IBDEI0CU ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,5882,2)
 ;;=^5009019
 ;;^UTILITY(U,$J,358.3,5883,0)
 ;;=L03.012^^30^385^101
 ;;^UTILITY(U,$J,358.3,5883,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5883,1,3,0)
 ;;=3^Cellulitis of Left Finger
 ;;^UTILITY(U,$J,358.3,5883,1,4,0)
 ;;=4^L03.012
 ;;^UTILITY(U,$J,358.3,5883,2)
 ;;=^5009020
 ;;^UTILITY(U,$J,358.3,5884,0)
 ;;=L03.021^^30^385^24
 ;;^UTILITY(U,$J,358.3,5884,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5884,1,3,0)
 ;;=3^Acute Lymphangitis of Right Finger
 ;;^UTILITY(U,$J,358.3,5884,1,4,0)
 ;;=4^L03.021
 ;;^UTILITY(U,$J,358.3,5884,2)
 ;;=^5009022
 ;;^UTILITY(U,$J,358.3,5885,0)
 ;;=L03.022^^30^385^18
 ;;^UTILITY(U,$J,358.3,5885,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5885,1,3,0)
 ;;=3^Acute Lymphangitis of Left Finger
 ;;^UTILITY(U,$J,358.3,5885,1,4,0)
 ;;=4^L03.022
 ;;^UTILITY(U,$J,358.3,5885,2)
 ;;=^5009023
 ;;^UTILITY(U,$J,358.3,5886,0)
 ;;=L03.031^^30^385^111
 ;;^UTILITY(U,$J,358.3,5886,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5886,1,3,0)
 ;;=3^Cellulitis of Right Toe
 ;;^UTILITY(U,$J,358.3,5886,1,4,0)
 ;;=4^L03.031
 ;;^UTILITY(U,$J,358.3,5886,2)
 ;;=^5009025
 ;;^UTILITY(U,$J,358.3,5887,0)
 ;;=L03.032^^30^385^104
 ;;^UTILITY(U,$J,358.3,5887,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5887,1,3,0)
 ;;=3^Cellulitis of Left Toe
 ;;^UTILITY(U,$J,358.3,5887,1,4,0)
 ;;=4^L03.032
 ;;^UTILITY(U,$J,358.3,5887,2)
 ;;=^5009026
 ;;^UTILITY(U,$J,358.3,5888,0)
 ;;=L03.041^^30^385^26
 ;;^UTILITY(U,$J,358.3,5888,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5888,1,3,0)
 ;;=3^Acute Lymphangitis of Right Toe
 ;;^UTILITY(U,$J,358.3,5888,1,4,0)
 ;;=4^L03.041
 ;;^UTILITY(U,$J,358.3,5888,2)
 ;;=^5009028
 ;;^UTILITY(U,$J,358.3,5889,0)
 ;;=L03.042^^30^385^20
 ;;^UTILITY(U,$J,358.3,5889,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5889,1,3,0)
 ;;=3^Acute Lymphangitis of Left Toe
 ;;^UTILITY(U,$J,358.3,5889,1,4,0)
 ;;=4^L03.042
 ;;^UTILITY(U,$J,358.3,5889,2)
 ;;=^5009029
 ;;^UTILITY(U,$J,358.3,5890,0)
 ;;=M34.0^^30^385^249
 ;;^UTILITY(U,$J,358.3,5890,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5890,1,3,0)
 ;;=3^Progressive Systemic Sclerosis
 ;;^UTILITY(U,$J,358.3,5890,1,4,0)
 ;;=4^M34.0
 ;;^UTILITY(U,$J,358.3,5890,2)
 ;;=^5011778
 ;;^UTILITY(U,$J,358.3,5891,0)
 ;;=M34.1^^30^385^91
 ;;^UTILITY(U,$J,358.3,5891,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5891,1,3,0)
 ;;=3^CR(E)ST Syndrome
 ;;^UTILITY(U,$J,358.3,5891,1,4,0)
 ;;=4^M34.1
 ;;^UTILITY(U,$J,358.3,5891,2)
 ;;=^5011779
 ;;^UTILITY(U,$J,358.3,5892,0)
 ;;=M34.2^^30^385^273
 ;;^UTILITY(U,$J,358.3,5892,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5892,1,3,0)
 ;;=3^Systemic Sclerosis Induced by Drug/Chemical
 ;;^UTILITY(U,$J,358.3,5892,1,4,0)
 ;;=4^M34.2
 ;;^UTILITY(U,$J,358.3,5892,2)
 ;;=^5011780
 ;;^UTILITY(U,$J,358.3,5893,0)
 ;;=M34.81^^30^385^275
 ;;^UTILITY(U,$J,358.3,5893,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5893,1,3,0)
 ;;=3^Systemic Sclerosis w/ Lung Involvement
 ;;^UTILITY(U,$J,358.3,5893,1,4,0)
 ;;=4^M34.81
 ;;^UTILITY(U,$J,358.3,5893,2)
 ;;=^5011781
 ;;^UTILITY(U,$J,358.3,5894,0)
 ;;=M34.82^^30^385^276
 ;;^UTILITY(U,$J,358.3,5894,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5894,1,3,0)
 ;;=3^Systemic Sclerosis w/ Myopathy
 ;;^UTILITY(U,$J,358.3,5894,1,4,0)
 ;;=4^M34.82
 ;;^UTILITY(U,$J,358.3,5894,2)
 ;;=^5011782
 ;;^UTILITY(U,$J,358.3,5895,0)
 ;;=M34.83^^30^385^277
 ;;^UTILITY(U,$J,358.3,5895,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5895,1,3,0)
 ;;=3^Systemic Sclerosis w/ Polyneuropathy
 ;;^UTILITY(U,$J,358.3,5895,1,4,0)
 ;;=4^M34.83
 ;;^UTILITY(U,$J,358.3,5895,2)
 ;;=^5011783
 ;;^UTILITY(U,$J,358.3,5896,0)
 ;;=M34.89^^30^385^274
